104 related articles for article (PubMed ID: 1991267)
21. CA 50 and CA 19-9 antigen expression in normal, hyperplastic, and neoplastic thyroid tissue.
Vierbuchen M; Schröder S; Uhlenbruck G; Ortmann M; Fischer R
Lab Invest; 1989 May; 60(5):726-32. PubMed ID: 2716285
[TBL] [Abstract][Full Text] [Related]
22. Intercellular adhesion molecule-1 (ICAM-1) immunoreactivity in well-differentiated thyroid papillary carcinomas.
Tanda F; Cossu A; Bosincu L; Manca A; Ibba M; Massarelli G
Mod Pathol; 1996 Jan; 9(1):53-6. PubMed ID: 8821957
[TBL] [Abstract][Full Text] [Related]
23. Expression and function of class II antigens on gastric carcinoma cells and gastric epithelia: differential expression of DR, DQ, and DP antigens.
Sakai K; Takiguchi M; Mori S; Kobori O; Morioka Y; Inoko H; Sekiguchi M; Kano K
J Natl Cancer Inst; 1987 Nov; 79(5):923-32. PubMed ID: 2960847
[TBL] [Abstract][Full Text] [Related]
24. Loss of microsomal antigen in follicular and papillary carcinoma of the thyroid. An immunofluorescence and electron-microscopic study.
Pontius KI; Hawk WA
Am J Clin Pathol; 1980 Nov; 74(5):620-9. PubMed ID: 7004165
[TBL] [Abstract][Full Text] [Related]
25. Differential expression of HLA class II antigens in fetal human spleen: relationship of HLA-DP, DQ, and DR to immunoglobulin expression.
Edwards JA; Durant BM; Jones DB; Evans PR; Smith JL
J Immunol; 1986 Jul; 137(2):490-7. PubMed ID: 3522732
[TBL] [Abstract][Full Text] [Related]
26. Distribution of microsomal antigen in various types of thyroid tumour.
Doniach I; Perrin J
Clin Exp Immunol; 1973 May; 14(1):77-90. PubMed ID: 4577288
[TBL] [Abstract][Full Text] [Related]
27. Expression of MHC class II antigens in human B-cell leukaemia and non-Hodgkin's lymphoma.
Guy K; Krajewski AS; Dewar AE
Br J Cancer; 1986 Feb; 53(2):161-73. PubMed ID: 3513812
[TBL] [Abstract][Full Text] [Related]
28. Simultaneous expression of thyroid peroxidase and human leukocyte antigen-DR by human thyroid cells: modulation by thyrotropin, thyroid-stimulating antibody, and interferon-gamma.
Chiovato L; Lapi P; Mariotti S; Del Prete G; De Carli M; Pinchera A
J Clin Endocrinol Metab; 1994 Aug; 79(2):653-6. PubMed ID: 7913937
[TBL] [Abstract][Full Text] [Related]
29. Characterization of neural cell adhesion molecule (NCAM) expression in thyroid follicular cells: induction by cytokines and over-expression in autoimmune glands.
Vargas F; Tolosa E; Sospedra M; Catálfamo M; Lucas-Martín A; Obiols G; Pujol-Borrell R
Clin Exp Immunol; 1994 Dec; 98(3):478-88. PubMed ID: 7527744
[TBL] [Abstract][Full Text] [Related]
30. Induction of MHC class II molecules HLA-DR, -DP and -DQ and ICAM 1 in human podocytes by gamma-interferon.
Baudeau C; Delarue F; Hé CJ; Nguyen G; Adida C; Peraldi MN; Sraer JD; Rondeau E
Exp Nephrol; 1994; 2(5):306-12. PubMed ID: 7812737
[TBL] [Abstract][Full Text] [Related]
31. Lateral organization of the ICAM-1 molecule at the surface of human lymphoblasts: a possible model for its co-distribution with the IL-2 receptor, class I and class II HLA molecules.
Bene L; Balázs M; Matkó J; Möst J; Dierich MP; Szöllösi J; Damjanovich S
Eur J Immunol; 1994 Sep; 24(9):2115-23. PubMed ID: 7916294
[TBL] [Abstract][Full Text] [Related]
32. CD97: a dedifferentiation marker in human thyroid carcinomas.
Aust G; Eichler W; Laue S; Lehmann I; Heldin NE; Lotz O; Scherbaum WA; Dralle H; Hoang-Vu C
Cancer Res; 1997 May; 57(9):1798-806. PubMed ID: 9135025
[TBL] [Abstract][Full Text] [Related]
33. HLA-DR expression and lymphocytic infiltration in metastatic and non-metastatic papillary carcinoma of the thyroid.
Feinmesser M; Stern S; Mechlis-Frish S; Lubin E; Feinmesser R; Kristt D
Eur J Surg Oncol; 1996 Oct; 22(5):494-501. PubMed ID: 8903492
[TBL] [Abstract][Full Text] [Related]
34. Separate induction of MHC and thyroid microsomal antigen (McAg) expression on thyroid cell monolayers: enhancement of lectin-induced McAg expression by interferon-gamma.
Iwatani Y; Iitaka M; Gerstein HC; Row VV; Volpé R
J Clin Endocrinol Metab; 1987 Jun; 64(6):1302-8. PubMed ID: 3106398
[TBL] [Abstract][Full Text] [Related]
35. [Spontaneous expression of class II (HLA-DR) molecules in thyroid pathology].
Aguayo J; Pérez MV; Trincado P; Wohllk N; Pineda G
Rev Med Chil; 1991 Aug; 119(8):867-70. PubMed ID: 1844766
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical diagnosis of papillary thyroid carcinoma.
Cheung CC; Ezzat S; Freeman JL; Rosen IB; Asa SL
Mod Pathol; 2001 Apr; 14(4):338-42. PubMed ID: 11301350
[TBL] [Abstract][Full Text] [Related]
37. Intrathyroidal HLA-DR expression and T lymphocyte phenotypes in Graves' thyrotoxicosis, Hashimoto's thyroiditis and nodular colloid goitre.
Jansson R; Karlsson A; Forsum U
Clin Exp Immunol; 1984 Nov; 58(2):264-72. PubMed ID: 6238731
[TBL] [Abstract][Full Text] [Related]
38. HLA class II antigen expression in human papillomavirus-associated cervical cancer.
Glew SS; Duggan-Keen M; Cabrera T; Stern PL
Cancer Res; 1992 Jul; 52(14):4009-16. PubMed ID: 1377602
[TBL] [Abstract][Full Text] [Related]
39. Class I and II HLA antigen distribution in normal mucosa, adenoma and colon carcinoma: relation with malignancy and invasiveness.
Gutierrez J; López-Nevot MA; Cabrera T; Oliva R; Esquivias J; Ruiz-Cabello F; Garrido F
Exp Clin Immunogenet; 1987; 4(3):144-52. PubMed ID: 2856203
[TBL] [Abstract][Full Text] [Related]
40. MHC antigen expression in human oral squamous carcinoma cell lines.
Mutlu S; Matthews JB; Midda M; Scully C; Prime SS
J Pathol; 1991 Oct; 165(2):129-36. PubMed ID: 1744799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
